Skip to main content
. 2020 Mar 24;9(10):3425–3436. doi: 10.1002/cam4.2874

Table 3.

Reporting of sexual activity, sexual dissatisfaction, and BC decreased their sexual activity frequency in relation to comorbid chronic diseases

Comorbidity Total Sexual activity Sexual dissatisfaction BC decreased their sexual activity frequency
N (%) P a AOR N (%) P a AOR N (%) P a AOR
Hypertension
No 247 (72.4%) 66 (26.7)   Ref 59 (23.9)   Ref 142 (57.5)   Ref
Yes 94 (27.6%) 17 (18.1) .097 0.59 (0.29, 1.17) 22 (23.4) .926 1.23 (0.62, 2.43) 59 (62.8) .376 1.46 (0.83, 2.58)
Hyperlipidemia
No 239 (70.1%) 63 (26.4)   Ref 61 (25.5)   Ref 143 (59.8)   Ref
Yes 102 (29.9%) 20 (19.6) .183 0.71 (0.35, 1.43) 20 (19.6) .24 0.71 (0.35, 1.45) 58 (56.9) .61 0.88 (0.49, 1.56)
Hyperuricemia
No 325 (95.3%) 82 (25.2)   Ref 75 (23.1)   Ref 193 (59.4)   Ref
Yes 16 (4.7%) 1 (6.3) .084 0.21 (0.02, 1.71) 6 (37.5) .186 1.97 (0.61, 6.42) 8 (50.0) .456 0.65 (0.22, 1.95)
Diabetes mellitus
No 307 (90.0%) 81 (26.4)   Ref 68 (22.2)   Ref 182 (59.3)   Ref
Yes 34 (10.0%) 2 (5.9) .008 0.18 (0.04, 0.83) 13 (38.2) .036 2.92 (1.25, 6.79) 19 (55.9) .702 0.90 (0.41, 1.95)
Heart and cardiovascular
No 298 (87.4%) 71 (23.8)   Ref 69 (23.2)   Ref 171 (57.4)   Ref
Yes 43 (12.6%) 12 (27.9) .559 1.70 (0.75, 3.88) 12 (27.9) .494 1.61 (0.72, 3.63) 30 (69.8) .123 2.05 (0.96, 4.39)
Stroke
No 334 (98.0%) 81 (24.3)   Ref 78 (23.4)   Ref 196 (58.7)   Ref
Yes 7 (2.1%) 2 (28.6) .792 1.84 (0.33, 10.12) 3 (42.9) .23 3.18 (0.65, 15.58) 5 (71.4) .497 1.75 (0.32, 9.48)
Respiratory diseases
No 309 (90.6%) 74 (24.0)   Ref 76 (24.6)   Ref 182 (58.9)   Ref
Yes 32 (9.4%) 9 (28.1) .6 1.47 (0.59, 3.66) 5 (15.6) .256 0.54 (0.19, 1.54) 19 (59.4) .958 1.08 (0.49, 2.41)
Digestive diseases
No 186 (54.6%) 43 (23.1)   Ref 49 (26.3)   Ref 115 (61.8)   Ref
Yes 155 (45.5%) 40 (25.8) .565 1.20 (0.61, 2.40) 32 (20.7) .218 0.88 (0.43, 1.78) 86 (55.5) .236 0.67 (0.37, 1.21)
Musculoskeletal diseases
No 291 (85.3%) 71 (24.4)   Ref 66 (22.7)   Ref 175 (60.1)   Ref
Yes 50 (14.7%) 12 (24.0) .952 1.23 (0.55,2.79) 15 (30.0) .261 1.81 (0.83,3.93) 26 (52.0) .279 0.71 (0.36,1.41)
Number of comorbidity
0‐1 184 (53.9%) 53 (28.8)   Ref 41 (22.3)   Ref 112 (60.9)   Ref
2‐3 125 (36.7%) 24 (19.2)   0.83 (0.45, 1.53) 31 (24.8)   1.17 (0.65, 2.11) 71 (56.8)   0.93 (0.57, 1.54)
≥4 32 (9.4%) 6 (18.8) .115 0.91 (0.33, 2.47) 9 (28.1) .729 1.56 (0.64, 3.85) 18 (56.3) .735 1.05 (0.47, 2.33)

All models were adjusted for age, marital status, self‐reported general health status, and time since cancer diagnosis.

Models investigating each specific comorbid chronic disease were also adjusted for the number of comorbidity.

Bold face P < .05.

Abbreviations: AOR, adjusted odds ratio; BC, breast cancer.

a

Chi‐square test or Fisher's exact test.